(Q54075480)

24 May 2018

title

Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease--an open evaluation of efficacy and safety. (English)

1 reference

24 May 2018

1 reference

Bulling MT

1

1 reference

24 May 2018

Wing LM

series ordinal

2

1 reference

24 May 2018

Burns RJ

series ordinal

3

1 reference

24 May 2018

publication date

1 August 1991

1 reference

24 May 2018

Australian and New Zealand journal of medicine

published in

1 reference

24 May 2018

volume

21

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

397-400

1 reference

24 May 2018

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1991.TB01337.X

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1991.TB01337.X

Controlled-release levodopa/carbidopa. II. Sinemet CR4 treatment of response fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1991.TB01337.X

Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1991.TB01337.X

Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1991.TB01337.X

10.1111/J.1445-5994.1991.TB01337.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018